Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’

Servier completed its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular business is expected to close later this year. At the BIO International Convention, Servier’s top business development executive explained the rationale for these deals and how they fit the company’s overall strategy. The post Servier Executive: ‘We Are Not Looking…

Read More

How Payers Can Use AI to Improve the Healthcare Financial Experience

[Sponsored] Zelis CEO Amanda Eisel discussed how AI can create value when it is applied to measurable outcomes: simplifying claims workflows, reducing administrative burden, strengthening payment integrity, improving the payments experience, and empowering members to navigate their healthcare financial journey with confidence. The post How Payers Can Use AI to Improve the Healthcare Financial Experience…

Read More

Would Hunters Take a Lyme Disease Vaccine? We Asked

It’s tick season, possibly the worst in a decade. More and more Americans are being exposed to these parasites as climate change expands the range where they can survive. That means more people are also exposed to the bevy of health conditions they can cause, such as Rocky Mountain spotted fever, the alpha-gal-triggered red meat…

Read More